NSE filing, NSE: MOBIKWIK. Summary written from the filing by ALFA Finder's alert engine.
One Mobikwik Systems Ltd: key numbers
- Share price
- ₹219.55
- Market cap
- ₹1,736 Cr
- Revenue (annual)
- ₹1,119 Cr
- Net profit (annual)
- ₹-62.10 Cr
- P/E (TTM)
- 62.3×Sector 23.6×
- Promoter holding
- 25.21%+0.13% QoQ
- FII holding
- 3.50%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from One Mobikwik Systems Ltd
All →One Mobikwik Systems Other Announcement
One MobiKwik Systems Limited has filed an audio/video recording intimation dated 2026-11-02. The filing links to financial statements but contains no transaction, money or business event.
One Mobikwik Systems Results Correction
MobiKwik corrected its consolidated Q2 and H1 FY27 EPS from ₹0.75 to ₹1.50 per share. The error was an incorrect PDF upload, with no financial impact.
One Mobikwik Systems Investor Presentation: Key Takeaways
Q2 FY27 revenue from operations ₹2,957 Mn; record EBITDA ₹227 Mn (7.5% margin); PAT ₹118 Mn, fourth straight profitable quarter, driven by GMV growth and margin expansion.
One Mobikwik Systems Results Update
MobiKwik reported Q2 FY27 PAT of ₹11.8 crore and EBITDA of ₹22.7 crore. These are the company's highest-ever quarterly figures, marking its fourth consecutive profitable quarter.
One Mobikwik Systems Q2 FY27 Results: Turns Profitable, Net Profit ₹11.8 Cr
One Mobikwik Systems Ltd reported revenue from operations of ₹295.7 Cr (+9.4% YoY) and net profit of ₹11.8 Cr for Q2 FY27.
- Key figure
- Net profit ₹11.8 Cr
One Mobikwik Systems Board Meeting Date
One MobiKwik will hold a board meeting on November 2, 2026 to consider its Q2 and H1 FY27 unaudited results. The trading window stays closed until November 4, 2026.
Other regulatory approval announcements
All →John Cockerill India Regulatory Approval
John Cockerill India received Reserve Bank of India approval for acquiring shares of John Cockerill Metals International SA. This allows the company to proceed with the share-swap acquisition.
Gland Pharma Regulatory Approval
Gland Pharma received USFDA approval for Methylprednisolone Acetate Injectable Suspension USP in multiple vial formats. The product is bioequivalent to Pfizer's Depo-Medrol in a ~$214M US market.
City Union Bank Regulatory Approval
City Union Bank disclosed RBI approval for appointing Shri Sankaran G as Executive Director (Whole-time Director) for three years. The board appointment and formal disclosures will follow later.
- Execution
- Three years from the date of taking charge
Lupin Regulatory Approval
Lupin received US FDA approval for its generic Amifampridine Tablets 10 mg ANDA. As a first-to-file applicant, it is eligible for 180-day shared generic exclusivity.
Som Distilleries & Breweries Regulatory Approval
Som Distilleries received manufacturing licences for its Bhopal plant from the Madhya Pradesh Excise Department, plus product label and rate approvals. Manufacturing and sales are expected to resume soon.
AGI Infra Regulatory Approval
Agi Infra received RERA registration PBRERA-SAS80-PR1452-102026 from Punjab RERA for its Utopia by AGI group housing project in New Chandigarh. The registration is valid until 30 March 2031.
- Execution
- Valid up to March 30, 2031